These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31359391)

  • 21. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
    Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
    Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
    Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rexinoids Induce Differential Gene Expression in Human Glioblastoma Cells and Protein-Protein Interactions in a Yeast Two-Hybrid System.
    Hackney JF; Broatch JE; Dallal RA; Brotherson C; Livingston S; Sabir Z; Reshi SM; Faltermeier Petras SR; Mallick S; Applegate MT; Mellor NJ; Buss K; Blain JM; Wagner CE; Jurutka PW; Marshall PA
    ACS Chem Neurosci; 2024 Aug; 15(15):2897-2915. PubMed ID: 39012782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.
    Giner XC; Cotnoir-White D; Mader S; Lévesque D
    FASEB J; 2015 Oct; 29(10):4256-67. PubMed ID: 26148973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells.
    Mallick S; Marshall PA; Wagner CE; Heck MC; Sabir ZL; Sabir MS; Dussik CM; Grozic A; Kaneko I; Jurutka PW
    ACS Chem Neurosci; 2021 Mar; 12(5):857-871. PubMed ID: 33570383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
    Howell SR; Shirley MA; Ulm EH
    Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
    Dominguez M; Alvarez S; de Lera AR
    Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.
    Moerland JA; Zhang D; Reich LA; Carapellucci S; Lockwood B; Leal AS; Krieger-Burke T; Aleiwi B; Ellsworth E; Liby KT
    Sci Rep; 2020 Dec; 10(1):22244. PubMed ID: 33335263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
    Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
    Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.
    Sanchez PV; Glantz ST; Scotland S; Kasner MT; Carroll M
    Leukemia; 2014 Apr; 28(4):749-60. PubMed ID: 23823656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles.
    Marshall PA; Jurutka PW; Wagner CE; van der Vaart A; Kaneko I; Chavez PI; Ma N; Bhogal JS; Shahani P; Swierski JC; MacNeill M
    Pharmacol Res Perspect; 2015 Mar; 3(2):e00122. PubMed ID: 26038698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral retinoids and rexinoids in cutaneous T-cell lymphomas.
    Sokołowska-Wojdyło M; Lugowska-Umer H; Maciejewska-Radomska A
    Postepy Dermatol Alergol; 2013 Feb; 30(1):19-29. PubMed ID: 24278042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells.
    Benoit GR; Flexor M; Besançon F; Altucci L; Rossin A; Hillion J; Balajthy Z; Legres L; Ségal-Bendirdjian E; Gronemeyer H; Lanotte M
    Mol Endocrinol; 2001 Jul; 15(7):1154-69. PubMed ID: 11435615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
    Kim HT; Kong G; Denardo D; Li Y; Uray I; Pal S; Mohsin S; Hilsenbeck SG; Bissonnette R; Lamph WW; Johnson K; Brown PH
    Cancer Res; 2006 Dec; 66(24):12009-18. PubMed ID: 17178900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional modulations by RXR agonists are only partially subordinated to PPARalpha signaling and attest additional, organ-specific, molecular cross-talks.
    Martin PG; Lasserre F; Calleja C; Van Es A; Roulet A; Concordet D; Cantiello M; Barnouin R; Gauthier B; Pineau T
    Gene Expr; 2005; 12(3):177-92. PubMed ID: 16128002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid.
    Belyaeva OV; Klyuyeva AV; Vyas A; Berger WK; Halasz L; Yu J; Atigadda VR; Slay A; Goggans KR; Renfrow MB; Kane MA; Nagy L; Kedishvili NY
    PLoS One; 2024; 19(4):e0301447. PubMed ID: 38557762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics.
    Hanish BJ; Hackney Price JF; Kaneko I; Ma N; van der Vaart A; Wagner CE; Jurutka PW; Marshall PA
    Steroids; 2018 Jul; 135():36-49. PubMed ID: 29704526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
    Li Y; Zhang Y; Hill J; Kim HT; Shen Q; Bissonnette RP; Lamph WW; Brown PH
    Br J Cancer; 2008 Apr; 98(8):1380-8. PubMed ID: 18362934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamics-Based Strategy of Using Retinoic Acid Receptor and Retinoid X Receptor Agonists to Induce MicroRNA-10a and Inhibit Atherosclerotic Lesion.
    Lee DY; Chiu JJ
    Methods Mol Biol; 2019; 2019():143-169. PubMed ID: 31359395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3H-Imidazo[4,5-b]pyridine-6-carboxylic acid derivatives as rexinoids with reduced teratogenicity.
    Takamura Y; Takahashi M; Nishii M; Shibahara O; Watanabe M; Fujihara M; Kakuta H
    Bioorg Med Chem Lett; 2019 Aug; 29(15):1891-1894. PubMed ID: 31160175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.